Shay Capital’s Evolent Health EVH Stock Holding History

Shay Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,514	Closed	-$26.3K	–	544
2026 Q1	$26.3K	Sell	11,514 -30,000	-72%	-$95.2K	﹤0.01%	463
2025 Q4	$166K	Buy	41,514 +11,514	+38%	+$64K	0.02%	421
2025 Q3	$254K	Buy	+30,000	New	+$291K	0.02%	326
2025 Q1	–	Sell	-260,000	Closed	-$2.92M	–	353
2024 Q4	$2.92M	Buy	260,000 +22,500	+9%	+$395K	0.44%	54
2024 Q3	$6.72M	Buy	+237,500	New	+$6.12M	0.95%	18

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Shay Capital's EVH Position: Q2 2026 in Review

Shay Capital sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 11,514 shares — an estimated $26.3K sold.

Shay Capital first reported a position in EVH in Q3 2024 and held it in 5 quarters. The position peaked at $6.72M in Q3 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Shay Capital reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
Shay Capital sold 11,514 Evolent Health shares in Q2 2026, an estimated $26.3K.
Shay Capital first reported a position in Evolent Health in Q3 2024 and held it in 5 quarters.
Shay Capital's Evolent Health position peaked at $6.72M in Q3 2024.
199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.